Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 3Other hematologic neoplasm 2Lymphoid 2Myeloid 1CNS 1

Conditions

Lymphoma 447Precursor Cell Lymphoblastic Leukemia-Lymphoma 413Lymphoma, Large B-Cell, Diffuse 348Lymphoma, Non-Hodgkin 317Leukemia, Lymphocytic, Chronic, B-Cell 286Leukemia 260Lymphoma, Follicular 241Burkitt Lymphoma 217Lymphoma, Mantle-Cell 202Hodgkin Disease 193Leukemia, Myeloid, Acute 190Myelodysplastic Syndromes 172Lymphoma, B-Cell, Marginal Zone 142Multiple Myeloma 116Lymphoma, Large-Cell, Immunoblastic 116Lymphoma, B-Cell 103Recurrence 100Leukemia, Myelogenous, Chronic, BCR-ABL Positive 76Myeloproliferative Disorders 75Leukemia, Myeloid, Chronic-Phase 73Dendritic Cell Sarcoma, Interdigitating 73Leukemia, Myeloid, Accelerated Phase 72Leukemia, Myelomonocytic, Chronic 67Lymphoma, Large-Cell, Anaplastic 65Waldenstrom Macroglobulinemia 63Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 63Neoplasms, Plasma Cell 59Blast Crisis 58Primary Myelofibrosis 54Congenital Abnormalities 52

Interventions

Melphalan 2Cyclophosphamide 2Busulfan 2thymoglobulin 1fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Thiotepa 1Rituximab 1Levetiracetam 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
beta-Thalassemia × Cyclophosphamide × Lymphoid × Clear all
NCT05735717 2026-04-06

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
70 enrolled
CNSClassical hematologyLymphoidOther hematologic neoplasm

Chromosome 7, monosomy, Anemia, Refractory, with Excess of Blasts, Chromosome Aberrations, Influenza, Human, Neurofibromatosis 1, Leukemia, Myeloid, Acute, beta-Thalassemia, Neoplasm, Residual, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡